Annexon, Inc. (ANNX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

180 KIMBALL WAY SOUTH SAN FRANCISCO, CA 94080

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is deploying a rigorous, biomarker-driven development strategy designed to improve the probability of technical success over shorter development timelines.

Data as of 2021-07-25 17:49:34 -0400
Market Cap803.432 Million Shares Outstanding38.259 Million Avg 30-day Volume150.646 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.64273 52-week High/Low38.01 / 15.33 Next Earnings Date2021-08-16 Price to Cash FLow (P/CF) -33.0251
Data provided by IEX Cloud
View SEC Filings from ANNX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 3 -33.33% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 73 72 1.39% 21 (1.23%) 21 (1.22%) 0.0%
13F shares: 37.419 Million 36.209 Million 3.34% 14.038 Million 14.044 Million -0.04%
% Ownership 98.0637 94.8931 3.34% 36.789 36.8052 -0.04%
New Positions: 7 15 -53.33% 3 3 0.0%
Increased Positions 36 31 16.13% 5 8 -37.5%
Closed Positions 6 10 -40.0% 3 6 -50.0%
Reduced Positions 13 14 -7.14% 7 6 16.67%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Annexon, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ANNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

22.5 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

22.5 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LOVE DOUGLAS PRESIDENT & CEO

  • Officer
  • Director
 94,738 2021-06-07 4

YEDNOCK TED EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
 25,615 2021-06-03 3

SUN RICKY

  • Director
 10,000 2021-06-02 1

SATTER MUNEER A

  • Director
 10,000 2021-06-02 1

WIGGANS THOMAS G

  • Director
 10,000 2021-06-02 1

CHOI JUNG

  • Director
 10,000 2021-06-02 1

CARSON WILLIAM H.

  • Director
 10,000 2021-06-02 3

LEW JENNIFER EVP & CHIEF FINANCIAL OFFICER

  • Officer
 149,293 2021-05-27 3

KESWANI SANJAY EVP & CHIEF MEDICAL OFFICER

  • Officer
 182,956 2021-03-24 2

OVERDORF MICHAEL EVP & CHIEF BUSINESS OFFICER

  • Officer
 115,000 2021-02-25 1

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

BAIN CAPITAL LIFE SCIENCES FUND, L.P.

BCIP LIFE SCIENCES ASSOCIATES, LP

KOPPEL ADAM

BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

SCHWARTZ JEFFREY LAWRENCE

  • 10% Owner
 No longer subject to file 2020-07-28 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
 No longer subject to file 2020-07-28 0

FLYNN JAMES E

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
 No longer subject to file 2020-07-28 0

CLARUS LIFESCIENCES III, L.P.

CLARUS VENTURES III GP, L.P.

BLACKSTONE CLARUS III L.L.C.

BLACKSTONE HOLDINGS II L.P.

BLACKSTONE HOLDINGS I/II GP L.L.C.

BLACKSTONE GROUP INC

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
 No longer subject to file 2020-07-28 0

YOUNG WILLIAM

  • Director
 0 2020-07-23 0

BASKETT FOREST

  • 10% Owner
 0 2020-07-23 0

CUNNINGHAM EMMETT

  • Director
 0 2020-07-23 0

SONSINI PETER W.

  • 10% Owner
 0 2020-07-23 0

SANDELL SCOTT D

  • 10% Owner
 0 2020-07-23 0

MAKOWER JOSHUA

  • 10% Owner
 0 2020-07-23 0

MAKHZOUMI MOHAMAD

  • 10% Owner
 0 2020-07-23 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
 0 2020-07-23 0

NEW ENTERPRISE ASSOCIATES 15, L.P.

NEA PARTNERS 15, L.P.

NEA 15 GP, LLC

  • 10% Owner
 0 2020-07-23 0

GALLAGHER CAROL GILTNER

  • Director
 0 2020-07-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LOVE DOUGLAS - Director - Officer PRESIDENT & CEO

2021-06-09 16:32:54 -0400 2021-06-08 M 3,750 d 45,494 direct

LOVE DOUGLAS - Director - Officer PRESIDENT & CEO

2021-06-09 16:32:54 -0400 2021-06-08 M 3,750 $1.41 a 3,750 direct 4.4221 3.8091 -8.056 6.6988 8 -8.056 31

LOVE DOUGLAS - Director - Officer PRESIDENT & CEO

2021-06-09 16:32:54 -0400 2021-06-08 S 3,750 $22.55 d 0 direct yes 4.4221 3.8091 -8.056 6.6988 8 -8.056 31

LOVE DOUGLAS - Director - Officer PRESIDENT & CEO

2021-06-09 16:32:54 -0400 2021-06-07 M 3,750 d 49,244 direct

LOVE DOUGLAS - Director - Officer PRESIDENT & CEO

2021-06-09 16:32:54 -0400 2021-06-07 S 3,750 $22.31 d 0 direct yes 4.4221 3.8091 -8.056 6.6988 8 -8.056 31

LOVE DOUGLAS - Director - Officer PRESIDENT & CEO

2021-06-09 16:32:54 -0400 2021-06-07 M 3,750 $1.41 a 3,750 direct 4.4221 3.8091 -8.056 6.6988 8 -8.056 31

YEDNOCK TED - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-06-07 16:47:44 -0400 2021-06-03 M 15,000 d 25,615 direct

YEDNOCK TED - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-06-07 16:47:44 -0400 2021-06-03 M 15,000 $1.41 a 15,000 direct 0.9309 2.3493 0.8422 8.023 10 -1.9504 16

YEDNOCK TED - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-06-07 16:47:44 -0400 2021-06-03 S 2,184 $21.72 d 0 direct yes 0.9309 2.3493 0.8422 8.023 10 -1.9504 16

YEDNOCK TED - Officer EVP & CHIEF SCIENTIFIC OFFICER

2021-06-07 16:47:44 -0400 2021-06-03 S 12,816 $21.45 d 2,184 direct yes 0.9309 2.3493 0.8422 8.023 10 -1.9504 16

WIGGANS THOMAS G - Director

2021-06-04 17:12:11 -0400 2021-06-02 A 10,000 a 10,000 direct

CARSON WILLIAM H. - Director

2021-06-04 17:10:43 -0400 2021-06-02 A 10,000 a 10,000 direct

SATTER MUNEER A - Director

2021-06-04 17:14:42 -0400 2021-06-02 A 10,000 a 10,000 direct

CHOI JUNG - Director

2021-06-04 17:11:35 -0400 2021-06-02 A 10,000 a 10,000 direct

SUN RICKY - Director

2021-06-04 17:00:28 -0400 2021-06-02 A 10,000 a 10,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ANNEXON INC ANNX 2021-07-28 18:45:03 UTC -0.5004 0.5804 20000
ANNEXON INC ANNX 2021-07-28 18:15:03 UTC -0.5004 0.5804 20000
ANNEXON INC ANNX 2021-07-28 17:45:03 UTC -0.5004 0.5804 20000
ANNEXON INC ANNX 2021-07-28 17:15:03 UTC -0.5004 0.5804 20000
ANNEXON INC ANNX 2021-07-28 16:45:03 UTC -0.5004 0.5804 20000
ANNEXON INC ANNX 2021-07-28 16:15:02 UTC -0.5004 0.5804 20000
ANNEXON INC ANNX 2021-07-28 15:45:03 UTC -0.5004 0.5804 20000
ANNEXON INC ANNX 2021-07-28 15:15:03 UTC -0.5004 0.5804 20000
ANNEXON INC ANNX 2021-07-28 14:45:02 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-28 14:15:03 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-28 13:45:02 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-28 13:15:03 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-28 12:45:03 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-27 22:15:03 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-27 21:45:03 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-27 21:15:03 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-27 20:45:03 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-27 20:15:03 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-27 19:45:02 UTC -0.4757 0.5557 20000
ANNEXON INC ANNX 2021-07-27 19:15:02 UTC -0.4757 0.5557 20000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments